U.S., July 2 -- ClinicalTrials.gov registry received information related to the study (NCT07678619) titled 'Smart Analysis and Decision-Making for Emerging Infectious Diseases' on June 24.
Brief Summary: Emerging infectious diseases, such as COVID-19, mpox, and dengue fever, are characterized by rapid transmission, wide impact, and high uncertainty, posing ongoing threats to global public health. While China achieved significant success in COVID-19 control, the response also revealed key challenges, including fragmented information, delayed risk perception, experience-dependent assessment, and inefficiencies in complex decision-making.
This study aims to establish a smart technology system covering the full chain of "risk perception-situa...